Genco Shipping & Trading (GNK) Proxy filing summary

Executive summary

• Diana Shipping Inc., holding 14.7% of Genco's shares, is soliciting proxies to elect six new independent directors and support proposals aimed at maximizing shareholder value, including a strategic review and repeal of recent by-law amendments.

• Diana made a fully financed acquisition offer for Genco at $23.50 per share, a 31% premium to the pre-offer price, in partnership with Star Bulk Carriers, but the Genco board has refused to engage.

• The proxy contest centers on replacing the current board, opposing executive compensation practices, and challenging the company's poison pill and governance actions.

Voting matters and shareholder proposals

• Election of six Diana Nominees to the board, with a recommendation to withhold votes from the six incumbent directors.

• Advisory vote on executive compensation (Say on Pay Proposal), with a recommendation to vote against due to excessive pay and poor oversight.

• Proposal to amend the 2015 Equity Incentive Plan to increase available shares by 1,673,000, with a recommendation to vote against.

• Ratification of Deloitte & Touche LLP as auditors for 2026, with a recommendation to vote for.

• Ratification and extension of the Shareholder Rights Agreement (poison pill) to 2029, with a recommendation to vote against.

• Proposal to repeal any by-law amendments made by the board after August 28, 2025, without shareholder approval.

• Proposal for a post-meeting strategic review to explore alternatives for maximizing shareholder value.

Board of directors and corporate governance

• Diana's nominees are experienced, independent professionals from the shipping and legal sectors, with no prior positions at Genco.

• The current board is criticized for lack of engagement with acquisition proposals and for adopting defensive measures without shareholder input.

• Diana seeks to repeal recent by-law changes and ensure shareholder control over governance.